Joseph Tucker, PhD, CEO of Enveric Biosciences, Naples, FL, discusses using cannabinoids, specifically cannabidiol in a topical administration, to tackle the widespread problem of radiation dermatitis in cancer patients. Dr Tucker highlights the importance of strict clinical trials to test the efficacy and safety of cannabinoids, in order for physicians and patients to be comfortable using these treatments.
